Regulatory Focus: Programmed Reflexology Therapy Trial for Sleep Quality in Adults with Poor Sleep Quality

By Dr. Hatem Rabeh · Published February 11, 2026 · Updated March 16, 2026

Regulatory notice: a ClinicalTrials.gov study tests programmed reflexology therapy for sleep quality in adults with poor sleep quality, detailing manual and electric foot massage approaches and regulatory relevance.

The study listed as NCT07402460 is sponsored by National Taipei University of Nursing and Health Sciences. It targets individuals with poor sleep quality and evaluates changes in sleep quality, insomnia symptoms, fatigue and heart rate variability after reflexology based interventions. The trial is currently active but not recruiting, according to public records. As of February 15, 2026 the record shows ongoing activity and no recruitment status change.

The trial design centers on two behavioral interventions. The first is manual reflexology treatment delivered by trained practitioners. The second uses an electric massager to deliver a feet massage commonly described as FEM in the trial materials. Both approaches seek to impact sleep related outcomes while preserving participant safety under standard research oversight.

What is being studied and why does it matter for sleep quality?

The title of the trial signals a focus on sleep quality and related symptoms in adults with poor sleep quality. The intervention set includes manual reflexology and a feet massage performed with an electric massager device. The study seeks to determine whether these non drug modalities can influence key measures such as sleep quality, insomnia symptoms and fatigue, as well as heart rate variability which is often used as a frontline marker of autonomic balance. The sponsor and the population are clearly described in the record, underscoring a research oriented approach rather than a marketing claim.

From a regulatory perspective the use of a massage based protocol in research highlights the importance of device and practitioner safety. Reflexology and the FEM based massage may involve devices and therapy procedures, which require appropriate oversight and risk management in line with medical device regulations. The description in public records is limited to the study purpose and methods, which helps ensure that any later marketing claims would rely on robust evidence rather than initial trial status.

How is the trial designed and who sponsors it?

The ClinicalTrials.gov entry confirms two behavioral intervention arms. One arm uses manual reflexology delivered by trained professionals. The other arm deploys an electric foot massage device to deliver a FEM based approach. The primary sponsor is National Taipei University of Nursing and Health Sciences. The record notes the study is active and not currently recruiting, a status that informs stakeholders about the stage of evidence development without implying commercial availability.

This section reflects the lack of a drug component. There is no indication of a marketing authorization path for devices within the entry. Instead the focus remains on procedural safety, informed consent and appropriate institutional oversight typical for clinical protocol documents. Such framing is relevant for regulatory teams evaluating where a potential product could fit in later stages if positive results emerge.

What outcomes are measured and what regulatory implications exist for device based therapies?

The planned outcomes include changes in sleep quality, insomnia symptoms, fatigue and heart rate variability. These endpoints map to both patient reported outcomes and physiologic indicators, offering a multifaceted view of potential benefits. In a regulatory context this helps clinicians and regulatory teams anticipate the kinds of evidence needed for future device related claims. The dual intervention design also requires clear delineation of safety and performance expectations for both reflexology modalities.

In addition to outcomes the entry highlights safety considerations inherent to non drug interventions. The presence of an electric foot massage device implies evaluation of device related risks, operator technique, sanitation and user instructions. Regulatory assessments would focus on risk management, labeling and the need for qualified operators when a device is used in research. The cited sponsor supports institutional review and data governance, which remains essential as investigators consider later steps if results prove meaningful.

What safety and regulatory considerations apply to reflexology based trials?

Safety considerations center on non invasive procedures performed by trained personnel. The trial setting must enforce informed consent, proper screening and monitoring for adverse events. From a device perspective any electronic massager used in the study would be subject to safety testing and clean handling guidance to minimize skin irritation or other risks. Researchers should document risk management measures and ensure continuity of care for participants.

Regulatory readers should note that the current entry does not imply marketing authorization. If findings support clinical use or market introduction, sponsors would need to pursue the appropriate regulatory pathway for devices and provide evidence of safety, performance and intended use in line with MDR Annex XIV style language. The university sponsor provides the oversight expected for non commercial research with human participants.

Conclusion

This report notes the ongoing trial status and describes the interventions in plain regulatory language. The evidence path remains exploratory at this stage. Stakeholders should watch for updates in the clinical trial registry and for any publications that might inform future device based use.